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Abstract: Three new secoiridoids, swertiakoulactone (1) and swertiakosides A and B (2 and 3), were isolated from Swertia 
kouitchensis. Their structures were elucidated by comprehensive spectroscopic analyses including MS, IR, 1D and 2D NMR data. 
By the anti-hepatitis B virus (HBV) assay on Hep G 2.2.15 cells line in vitro, compound 1 showed moderate activities inhibiting the 
HBsAg secretion (IC50 = 1.10 mM, SI = 4.39) and HBV DNA replication (IC50 = 1.16 mM, SI = 4.12). 
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Introduction 
Swertia kouitchensis (Gentianaceae), is a perennial herb 
mainly distributed in Yunnan, Sichuan, and Guizhou provinces 
of China,1 which was widely used as a fork medicine to treat 
jaundice, indigestion and sore throat.2 Its congener plant S. 
mileensis, well-known as Qing-Ye-Dan in Chinese, has been 
documented in Chinese Pharmacopoeia (1977–2005 editions) 
for treatment of viral hepatitis.3 Our previous investigation on 
S. mileensis resulted in a series of novel anti-HBV active se-
coiridoid dimers with C18 and C20 skeletons (swerilactones A 
and B4, C and D5) and secoiridoid trimers with C29 skeleton 
(swerilactones H–K)6, as well as three unusual aromatic lac-
tones (swerilactones E–G)7 and three new secoiridoid glyco-
side dimers (swerilactosides A–C)8. Presently, xanthones, 
triterpenoids and sterols except for iridoids have been reported 
from S. kouitchensis.9,10 As an on-going search for anti-HBV 
active compounds from natural resources, our investigation on 
S. kouitchensis led to the isolation of three new compounds, 
including one secoiridoid, swertiakoulactone (1), and two se-
coiridoid glycosides, swertiakosides A and B (2 and 3). Herein, 
we report the isolation, structural elucidation, and anti-HBV 
properties of compounds 1–3. 
 
Results and Discussion 
Swertiakoulactone (1) was obtained as amorphous solids. 
The positive HRESIMS spectrum showed the [M + H]+ ion 
peak at m/z 195.0654 (calcd 195.0657) in accordance with the 
molecular formula C10H10O4, indicating six degrees of 
unsaturation. The IR spectrum suggested the presence of C=O 
(1714, 1667 cm−1) and C=C bonds (1639 cm−1). The 1H and 
13C NMR (DEPT) spectra (Table 1) displayed ten carbon 
resonances due to four quaternary carbons, three methines, two 
methylenes and one methyl group, of which one lactone, one 
aldehyde group and two double bonds were revealed. Besides 
the four degrees of unsaturation ascribed to two C=O and two 
C=C groups, the remaining two degrees of unsaturation 
required compound 1 to contain a dicyclic ring system. A δ-
lactone ring was characterized from the 1H NMR [δH 2.71, (1H, 
dt, 18.2, 6.4), 2.66 (1H, dt, 18.2, 6.4), 4.44 (2H, t, J = 6.4 Hz)] 
and 13C NMR [δC 163.8 (C-11), 101.1 (C-4), 171.6 (C-5)] data, 
which was supported by the 1H–1H COSY correlated signal of 
H-6/H-7 and HMBC correlations from H-7 to C-5 and C-11, 
and from H-6 to C-4 (Figure 1). In addition, a γ-pyran ring 
joined with the δ-lactone at C-4 and C-5 positions was 
deduced from the 1H NMR [δH 7.29, (1H, s), 5.60 (1H, q, J = 
6.5 Hz)] and 13C NMR [δC 129.6 (C-2), 135.4 (C-3), 74.1 (C-
9)] data, together with the HMBC experiment (Figure 1) (H-
3/C-5, C-11; and H-9/C-3, C-5). The residual two carbons, 
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ascribed as one methyl and one conjugated aldehyde groups, 
were assigned at C-9 and C-2 respectively, by the correlations 
of H-9/Me-10 in 1H–1H COSY spectrum and H-1/C-3, C-9 in 
HMBC spectrum (Figure 1). Thus, the structure of 
swertiakoulactone (1) was assigned as shown. 
Swertiakoside A (2), amorphous solids, possessed the 
molecular formula C16H20O9 deduced from negative ESIMS 
([M − H]−, m/z 355) and HRESIMS (m/z 355.1034, ([M − H]−; 
calcd 355.1029)) analyses. The IR spectrum displayed the 
absorption bands for OH (3431 cm−1), C=O (1708 cm−1), C=C 
(1636 cm−1), and C-O-C (1104, 1047 cm−1) functionalities. 
The 13C NMR (DEPT) spectrum (Table 1) exhibited sixteen C 
atoms assignable to three quaternary carbons, nine methines 
and four methylenes. The observed carbon signals [δC 98.9 (C-
1′), 81.6 (C-2′), 76.2 (C-3′), 70.7 (C-4′), 79.0 (C-5′), 62.5 (C-
6′)] in the 13C NMR spectrum, in combination with the 
coupling constant (J = 7.1 Hz) of the anomeric H atom (δH 
4.97) in 1H NMR spectrum suggested the β-D-glucosyl 
moiety.11 The NMR data of swertiakoside A (2) were similar 
to those of swertiajaposide A,11 except for the absence of 
methoxyl group, as well as the downfield shift of C-2′ from δC 
74.7 (d) in swertiajaposide A to 81.6 (d) in compound 2. The 
HMBC correlations (Figure 2) of H-1 [δH 5.77 (d, J = 2.0 Hz)] 
with C-2′, and H-1′ [δH 4.97 (d, J = 7.1 Hz)] with C-3 
indicated the linkage of C(1)–O–C(2′) and C(3)–O–C(1′). 
Therefore, the planar structure of compound 2 was constructed. 
In the ROESY spectrum (Figure 2), correlations of H-3 with 
H-1′ and H-9 indicated the same orientation of H-3, H-1′ and 
H-9. Based on the structure of 2 shown in figure 2, the 
anomeric H-atom (H-1′) was put at the upside of the reference 
plane (β-orientation), therefore, H-3 and H-9 were also 
determined as β-orientation. Similarly, the obviously 
correlated signal of H-1 with H-10 indicated the α-orientation 
of H-1, which was consistent with the undetected correlation 
of H-1 with H-3. Hence, the structure of swertiakoside A (2) 
was established. 
Swertiakoside B (3) was obtained as amorphous solids. Its 
molecular formula C18H26O10 was determined by positive 
ESIMS ([M + Na]+, m/z 425) and HRESIMS (m/z 425.1434, 
([M + Na]+; calcd 425.1423)). Acid hydrolysis of compound 3 
with 10% H2SO4 yielded glucose, which was identified by 
comparison with an authentic sample on PC (see Experiment 
Part).12 Comparison of its 1D NMR spectra (Table 1) with 
those of 3-epi-swertiajaposide C13 showed high similarity. The 
major difference was that the methoxyl group in 3-epi-
swertiajaposide C [δC 57.7 (t)] was replaced by an ethoxyl 
group in compound 3 [δC 67.5 (t), 15.2 (q)], which was 
confirmed by the 1H–1H COSY correlation of H-12/H-13 and 
HMBC correlation from H-3 [δH 5.67 (s)] to C-12 [δC 67.5 (t)]  
(Figure 3). The relative configuration of 3 was deduced based 
on ROESY analyses and NMR comparison, which was 
identical to 3-epi-swertiajaposide C13. The ROESY cross-peak 
(Figure 3) between H-1 and Me-10 suggested the (Z)-
configuration of C(8) = C(9) bond. Similarly, the glucosyl 
group at C-1 and the ethoxyl group at C-3 were proposed as 
trans-orientation based on the 13C NMR data [δC 90.9 (C-1), 
94.4 (C-3)], as well as the undetected correlation of H-1 with 
H-3 in the ROESY spectrum.13 Consequently, the structure of 
swertiakoside B (3) was elucidated as shown. 
Compounds 1–3 were evaluated for their anti-HBV activi-
ties, namely inhibiting the secretion of hepatitis B surface an-
tigen (HBsAg) and hepatitis B e antigen (HBeAg), as well as 
HBV DNA replication in Hep G 2.2.15 cells, as reported pre-
viously (tenofovir was used as the positive control).6 The re-
sults showed that compound 1 exhibited moderate activity 
inhibiting the secretion of HBsAg with an IC50 value of 1.10 
mM (SI = 4.39) and HBV DNA replication with an IC50 value 
of 1.16 mM (SI = 4.12). However, compounds 2 and 3 showed 
no anti-HBV activity and cytotoxicity at the highest tested 
concentration (2.86 mM and 1.73 mM, respectively). 
 
Experimental Section 
General Experimental Procedures. Column chromatog-
raphy (CC): silica gel (SiO2; 200–300 mesh, Qingdao Makall 
Chemical Co. Ltd., Qingdao, P. R. China), Sephadex LH-20 
(Pharmacia, Fine Chemical Co. Ltd. Uppsala, Sweden), and 
Lichroprep RP-18 (40–63 μm; Merck, D-Darmstadt). Frac-
tions were monitored by TLC, visualizing by spraying with 
10% H2SO4 in EtOH followed by heating. Optical rotations: 
Jasco model 1020 polarimeter (Horiba, Tokyo, Japan). UV 
Spectra: UV-210A spectrometer (Shimadzu, Kyoto, Japan); 
λmax (log ε) in nm. IR Spectra: Bio-Rad FTS-135 spectrometer 
(Bio-Rad, Hercules, California, USA); KBr pellets; in cm−1. 1H 
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Figure 3.  The key 2D NMR correlations for 3. 
 
COSY (▬)      HMBC (H→C) 























COSY (▬)  HMBC (H→C)  ROESY (H↔H) 
Figure 2.  The key 2D NMR correlations for 2.
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spectrometers (Bruker, Bremerhaven, Germany); with TMS as 
internal standard; δ in ppm, J in Hz. ESI and HRESIMS: VG 
Auto Spec-3000 spectrometer (VG, Manchester, UK); in m/z 
(rel. %). 
 
Plant Material. The whole plant of S. kouitchensis was col-
lected in Jianshui County, Yunnan Province, China, in De-
cember 2008, and authenticated by Prof. Li-Gong Lei, Kun-
ming Institute of Botany, Chinese Academy of Sciences. A 
voucher specimen (No. 2008-12-12) has been deposited in the 
Laboratory of Antivirus and Natural Medicinal Chemistry, 
Kunming Institute of Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The whole plant of S. kouitchen-
sis (1.5 kg) was powered and successively extracted with 90% 
and 50% EtOH under reflux for 2 times (each 5 L, 2 h). The 
extracts were combined, and evaporated under reduced pres-
sure. The crude residue was suspended in H2O, and partitioned 
with petroleum ether, EtOAc, and n-butanol successively. The 
EtOAc part (72 g) was subjected to a SiO2 CC (700g, 200−300 
mesh) and eluted with gradient CHCl3/MeOH/H2O (100:0:0, 
95:5:0, 90:10:0, 80:20:2, 70:30:3) to yield six fractions Frs. A-
F. Fr. B (6.6 g) was subjected to a SiO2 CC with a gradient 
elution of CHCl3/Me2CO (from 9:1 to 5:5) to supply Frs. B1–
B3. Fr. B3 (1.4 g) was chromatographed on a SiO2 CC eluted 
with PE/Me2CO (7:3) and then purified on Sephadex LH-20 
(MeOH), yielding 1 (7 mg). Fr. E (2.2 g) was subjected by RP-
18 CC (MeOH/H2O 2:8), and subsequently performed on SiO2 
CC with CHCl3/MeOH (9:1–8:2) and purified by Sephadex 
LH-20 (MeOH) to obtain 2 (20 mg) and 3 (25 mg). 
 
Swertiakoulactone (1): amorphous solids; [α]20D = − 4.9 (c 
0.27, CHCl3); UV (CHCl3) λmax (log ε) 338 (3.6), 261 (3.8) nm; 
IR (KBr) max 2919, 2850, 1714, 1667, 1639, 1571, 1427, 
1168 cm–1; NMR data, see Table 1; ESIMS m/z 195 ([M + 
H]+); positive ion HRESIMS m/z 195.0654 (calcd for C10H11O4 
[M + H]+, 195.0657). 
 
Swertiakoside A (2): amorphous solids; [α]20D = − 55.6 (c 
0.29, MeOH); UV (MeOH) λmax (log ε) 265 (3.4) nm; IR (KBr) 
max 3431, 1708, 1636, 1104, 1047 cm–1; NMR data, see Table 
1; ESIMS m/z 355 ([M − H]−); negative ion HRESIMS m/z 
355.1034 (calcd for C16H19O9 [M − H]−, 355.1029). 
 
Swertiakoside B (3): amorphous solids; [α]20D  = − 53.0 (c 
0.08, MeOH); UV (MeOH) λmax (log ε) 272 (4.0), 202(3.7) nm; 
IR (KBr) max 3440, 1631, 1075, 1059 cm–1; NMR data, see 
Table 1; ESIMS m/z 425 ([M + Na]+); positive ion HRESIMS 
m/z 425.1434 (calcd for C18H26NaO10 [M + Na]+, 425.1423). 
 
Acid Hydrolysis of Swertiakoside B (3). A solution of 3 (3 
mg) in a mixture of MeOH (1.0 mL) and 10% H2SO4 (1.0 mL) 
was refluxed for 2 h. The hydrolysate was allowed to cool, 
diluted with 2 mL of H2O, and extracted with 4 mL of AcOEt 
for 3 times. The aq. layer was neutralized with aq. Ba(OH)2 
and concentrated in vacuum to give a residue, in which glu-
cose (from 3) was identified by comparison with the authentic 
sample (BuOH/AcOEt/H2O 4:1:5, upper layer, Rf 0.45; 
PhOH/H2O 4:1, Rf 0.50) on PC: visualized by spraying with 
phthalic acid/aniline reagent (1.66 g phthalic acid and 0.93 g 
aniline dissolved in 100 mL H2O/sat. BuOH), followed by 
heating. 
 
In Vitro Anti-HBV Assay. The anti-HBV procedure was 
performed according to our previous report.8 Briefly, com-
pounds 1–3 were evaluated in the Hep G 2.2.15 cell line, 
which was stably transfected (Lipofectamine 2000 reagent; 
Invitrogen; Carlsbad, CA, USA) with the HBV genome. The 
Table 1. 1H and 13C NMR data for 1–3. 
 
Pos. 
1a  2b  3b 
δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) δC 
1 9.46, s 189.4, CH  5.77, d (2.0) 91.3, CH 6.23, s 90.9, CH
2  129.6, C       
3 7.29, s 135.4, CH  5.35, s 95.4, CH  5.67, s 94.4, CH 
4  101.1, C   121.3, C    119.8, C 
5  171.6, C   158.7, C 147.1, C
6a 2.71, dt (18.2, 6.4) 
2.66, dt (18.2, 6.4) 
27.5, CH2  2.74, m 28.7, CH2  2.76, m 23.8, CH2 
6b 2.42, m 1.26, m  
7a 4.44, t (6.4) 63.6, CH2  4.45, dd (8.6, 3.8) 66.7, CH2  4.48, m 66.7, CH2 
7b 4.37, m  
8    5.68, m 132.8, CH  6.41, q (14.5, 7.2) 136.6, CH 
9 5.60, q (6.5) 74.1, CH  3.13, br d (8.4) 50.7, CH   130.6, C 
10 1.44, d (6.5) 20.6, CH3  5.31, m 121.5, CH2  1.97, d (7.2) 14.3, CH3 
11  163.8, C   163.9, C   165.6, C  
12a       4.07, m 67.5, CH2 
12b      3.73, m  
13       1.25, t (7.1) 15.2, CH3 
1′    4.97, d (7.1)  98.9, CH  4.83, d (7.9) 99.0, CH 
2′    3.33, m 81.6, CH  3.21, dd (9.0, 7.9) 75.0, CH 
3′    3.55, t (8.9) 76.2, CH  3.44, t (9.0) 78.1, CH 
4′    3.31, m 70.7, CH  3.29, m  71.7, CH 
5′    3.34, m 79.0, CH   3.38, m  78.5, CH 
6′a    3.86, dd (12.0, 1.9) 62.5, CH2  3.92, dd (11.5, 1.8) 63.0, CH2 
6′b    3.65, dd (12.0, 5.6)  3.68, dd (11.5, 6.1)  
aRecorded in CDCl3 at 600 MHz; bRecorded in CD3OD at 500 MHz. 
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toxicity of the compounds was assayed by using a modified 
MTT (GIBCO Invitrogen, Carlsbad, CA, USA) method. 
DMSO (Gibco; solvent control) alone was added to each cul-
ture as a solvent control. All the compounds evaluated were 
dissolved in DMSO for the assays of anti-HBV activity and 
cytotoxicity. The concentration of DMSO in the culture was 
kept below 2.5 μL mL–1 to ensure that the growth of the cells 
was not affected. 
 
Cell Line and Cell Culture. The widely used Hep G 2.2.15 
cell line was applied for the assay of anti-HBV activities. In 
this study, Hep G 2.2.15 cells established from a hepatoma cell 
line Hep G 2 (ATCC, Manassas, VA, USA) were cultured in 
RPMI-1640 (GIBCO) medium supplemented with 10% fetal 
calf serum (GIBCO), 100 μg mL–1 G148 (GIBCO), 100 IU/mL 
penicillin (GIBCO), and 100 IU/mL streptomycin (GIBCO). 
All cultures were maintained at 37C in a moist atmosphere 
containing 5% CO2. 
 
Analysis of Secreted HBV Antigens. The sub-toxic con-
centration of the identified compounds was measured with a 
serial dilution in 96-well microplates in which cells were seed-
ed at a density of 3×104 cells/mL and cultured at 37 C, 5% 
CO2 for 12 days. After incubation, the cells and supernatants 
were collected. The levels of HBsAg and HBeAg in the super-
natants were assayed with an ELISA (AutoBio Diagnostics 
Co., Ltd., Beijing, P. R. of China) method. The absorbance (A) 
of each well was measured at 490 nm using a microplate read-
er (Model 680, Bio-Rad, Inc., Hercules, CA, USA). 
 
Determination of HBV DNA Replication. HepG 2.2.15 
cells were seeded in 24 well culture plates at a density of 5 × 
105 cells per well. Every 2 days, medium was changed. After 6 
days, compounds were added to the cell cultures, and fresh 
medium was fed every other day for another 6 days. Cells 
were collected and total DNA was isolated by using TIANamp 
Gemomic DNA Kit (TIANGEN, Biotech Co., Ltd, China) 
following the manufacturer’s instructions. For detection of 
HBV DNA, a real-time PCR assay was used. 
 
Cytotoxicity Assay. The toxicity of compounds 1–3 was as-
sayed by a modified MTT method. In brief, the samples were 
prepared at different concentrations. After Hep G 2.2.15 cells 
had been seeded in a 96-well microplate for 4 h, the samples 
(20 mL) were placed in each well and incubated for 3 days at 
37C; then, 0.1 mL MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-
diphenyltetrazolium bromide, 400 mg mL–1] was added for 4 h. 
After removal of MTT medium, DMSO (100 mL/well) was 
added into the microplate for 10 min. The formazan crystals 
were dissolved, and the absorbance was measured on a micro-
plate reader at 490 nm. 
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